Glidiab - is oral hypoglycemic medication.
Pharmacological action Glidiaba
Glidiab a hypoglycemic drug, its derivatives are sulfonylureas II generation. Cure improves the sensitivity of tissues to insulin in the periphery, stimulates insulin secretion in the pancreas, or rather in its beta-cells, and causes display of special actions insulinosekretornogo glucose. Glidiab reduces interval that is needed to start insulin secretion from the time the meal. With the help of the drug can stimulate the activity of intracellular enzymes. Also, these tablets is reduced early peak of insulin secretion and reduces glucose levels rise.
Besides effects on carbohydrate metabolism, Glidiab, opinions of experts confirm this, improves microcirculation, normalizes the permeability of blood vessels, it helps to restore the physiological process of parietal fibrinolysis, prevents the development of atherosclerosis and mikrotromboza reduces the sensitivity to adrenaline vessels.
Tablets Glidiab slow the progression of diabetic retinopathy, located on the nonproliferative stage.
The significant reduction in proteinuria occurs after prolonged use of the drug for diabetic nephropathy. It is noted that the drug does not increase body weight, as it does not cause hyperinsulinemia and acts at the early stage of insulin secretion. In addition, tablets Glidiab can reduce body weight in obese patients, subject to certain diet.
Release form and composition
Glidiab release tablets that contain in its composition of 80 mg of gliclazide. They are placed in the Valium planimetric package of 10 pieces. The carton pack is 6 packs.
According to the instructions, Glidiab shown to use people who are in the initial stages of diabetic microangiopathy.
In combination with other hypoglycemic agents Glidiab used to prevent blood rheological disorders.
Glidiab has the contraindications:
- type 1 diabetes, type 2 labile flow and juvenile type 1 diabetes;
- hypersensitivity to any component of the drug;
- coma and precoma,
- diabetic ketoacidosis;
- renal failure;
- infectious diseases;
- surgical intervention;
- severe microangiopathy.
Instructions Glidiaba: methods of use
Instruction Glidiabu indicates that the drug must be taken inside for half an hour before a meal twice a day.
The initial daily dose should be 80 mg, and the average dose - 160-320 mg. The dose or, more precisely, its value depends on the severity of the disease, age and level of glycemic control, as measured 2 hours after a meal.
Glidiab, patient testimonials confirm this, can have side effects:
- abnormal liver function;
- allergic reactions such as skin rash or itching;
- hypoglycemic coma, which can occur when an inadequate dose, or dosing regimen abuse;
- violation of the sensitivity;
- severity of epigastric.
Storage conditions and terms
Keep the drug should be protected from light, out of reach of children, dry place, temperature not exceeding 25
Glidiab pass for 4 years.